Piperonal

Piperonal

SCHEMBL6073053

O=Cc1ccc2c(c1)OCO2.O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.88
MTOR P42345 1/20 0.88
RAB9A P51151 1/20 0.88
VCP P55072 1/20 0.88
ALDH1A1 P00352 3/20 0.68
HSD17B10 Q99714 2/20 0.68
TDP1 Q9NUW8 1/20 0.68
CYP3A4 P08684 1/20 0.51
ATM Q13315 1/20 0.51
PTPN1 P18031 1/20 0.51
MAPT P10636 3/20 0.49
CYP19A1 P11511 2/20 0.49
MITF O75030 1/20 0.48
LMNA P02545 1/20 0.48
HSP90AA1 P07900 1/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
FBP1 P09467 1/20 0.47
CYP1A2 P05177 1/20 0.47
ABL1 P00519 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperonal SCHEMBL6073058 1.00 NPC1 (0.88) NPC1MTORRAB9AVCPALDH1A1
SCHEMBL744717 0.94 NPC1 (1.00) NPC1MTORRAB9AVCPALDH1A1
SCHEMBL16211885 0.94 NPC1 (1.00) NPC1MTORRAB9AVCPALDH1A1
SCHEMBL30577771 0.94 NPC1 (1.00) NPC1MTORRAB9AVCPALDH1A1
SCHEMBL744716 0.94 NPC1 (1.00) NPC1MTORRAB9AVCPALDH1A1
SCHEMBL4997484 0.84 VCP (0.82) NPC1MTORRAB9AVCPMAPT
SCHEMBL2742581 0.84 VCP (0.82) NPC1MTORRAB9AVCPMAPT
Piperonal SCHEMBL29411164 0.82 ALDH1A1 (1.00) NPC1MTORRAB9AVCPALDH1A1
Piperonal SCHEMBL1864802 0.82 ALDH1A1 (1.00) NPC1MTORRAB9AVCPALDH1A1
Piperonal SCHEMBL29318 0.82 ALDH1A1 (1.00) NPC1MTORRAB9AVCPALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006034234-A1 CRYSTALLINE FORM 3 OF ATRASENTAN HYDROCHLORIDE ABBOTT LABORATORIES (US) 2006-03-30 WO disclosed